A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of Melasma
Open accessThe DOI matches its Crossref record.
Abstract
Background . Multiple modalities have been used in the treatment of melasma with variable success. Niacinamide has anti-inflammatory properties and is able to decrease the transfer of melanosomes. Objective . To evaluate the therapeutic effect of topical niacinamide versus hydroquinone (HQ) in melasma patients. Patients and Methods . Twenty-seven melasma patients were randomized to receive for eight weeks 4% niacinamide cream on one side of the face, and 4% HQ cream on the other. Sunscreen was applied along the observation period. They were assessed by noninvasive techniques for the evaluation of skin color, as well as subjective scales and histological sections initially and after the treatment with niacinamide. Results . All patients showed pigment improvement with both treatments. Colorimetric measures did not show statistical differences between both sides. However, good to excellent improvement was observed with niacinamide in 44% of patients, compared to 55% with HQ. Niacinamide reduced importantly the mast cell infiltrate and showed improvement of solar elastosis in melasma skin. Side effects were present in 18% with niacinamide versus 29% with HQ. Conclusion . Niacinamide induces a decrease in pigmentation, inflammatory infiltrate, and solar elastosis. Niacinamide is a safe and effective therapeutic agent for this condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Postinflammatory Hyperpigmentation: Epidemiology, Clinical Presentation, Pathogenesis and Treatment
Kaufman, B. P., Aman, T., & Alexis, A. F. (2018) · American Journal of Clinical Dermatology · doi:10.1007/s40257-017-0333-6 · Cited by 155
Skin whitening cosmetics: feedback and challenges in the development of natural skin lighteners
Burger, P., Landreau, A., Azoulay, S., Michel, T., & Fernandez, X. (2016) · Cosmetics · doi:10.3390/cosmetics3040036 · Cited by 152
Photoprotection in skin of color
Seck, S., Hamad, J., Schalka, S., & Lim, H. W. (2022) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-022-00314-z · Cited by 20
Zhang, C., Song, W., Yu, B., Chen, X., Fan, W., Gao, L., Gu, J., Hao, F., He, W., Ju, Q., et al. (2024) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19857 · Cited by 16
“50 51-53 Morus alba extract inhibits tyrosinase activity, consequently suppressing melanin formation.”
Skincare ingredients recommended by cosmetic dermatologists: A Delphi consensus study.
Alvarez, G. V., Kang, B. Y., Richmond, A. M., Hoss, E., Sulewski, R., Minkis, K., Rozenberg, S. S., Antonovich, D., Boucher, A., Bernstein, E. F., et al. (2025) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2025.04.021 · Cited by 10
(2014) · Europe PMC (PubMed Central) · Cited by 7
Metadata
- Authors
- Navarrete-Solís, J., Castanedo-Cázares, J. P., Torres-Álvarez, B., Oros-Ovalle, C., Fuentes-Ahumada, C., González, F. J., Martínez-Ramírez, J. D., & Moncada, B.
- Venue
- Dermatology Research and Practice
- Publisher
- Wiley
- Published
- 2011
- Volume
- 2011
- Pages
- 1-5
- ISSN
- 1687-6105 (ISSN-L)
- 1687-6113
- OpenAlex
- W2139901484
- Cited by
- 159
- References
- 0
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.